Perioperative fatigue in patients with diffuse glioma.
Adolescent
Adult
Aged
Aged, 80 and over
Brain Neoplasms
/ epidemiology
Fatigue
/ epidemiology
Female
Glioma
/ epidemiology
Humans
Karnofsky Performance Status
Male
Middle Aged
Perioperative Period
Postoperative Complications
/ epidemiology
Postoperative Period
Prospective Studies
Surveys and Questionnaires
Young Adult
Brain neoplasms
Fatigue
Glioma
Perioperative period
Surgery
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
25
10
2019
accepted:
16
01
2020
pubmed:
25
1
2020
medline:
21
11
2020
entrez:
25
1
2020
Statut:
ppublish
Résumé
Few studies have assessed fatigue in relation to glioma surgery. The purpose of this study was to explore the prevalence of pre- and postoperative high fatigue, perioperative changes, and factors associated with pre- and postoperative high fatigue in patients undergoing primary surgery for diffuse glioma. A total of 112 adult patients were prospectively included. Patient-reported fatigue was assessed before and one month after surgery using the cancer-specific European Organization for Research and Treatment of Cancer questionnaire fatigue subscale. The scores were dichotomized as high fatigue (≥ 39) or low fatigue (< 39). A change in score of ≥ 10 was considered as a clinically significant change. Factors associated with pre- and postoperative high fatigue were explored in multivariable regression analyses. High fatigue was reported by 45% of the patients preoperatively and by 42% of the patients postoperatively. Female gender and low Karnofsky Performance Status (KPS) were associated with preoperative high fatigue, while postoperative complications, low KPS and low-grade histopathology were associated with postoperative high fatigue. In total 35/92 (38%) patients reported a clinically significant improvement of fatigue scores after surgery, 36/92 (39%) patients reported a clinically significant worsening of fatigue scores after surgery, and 21/92 (23%) patients reported no clinically significant change in fatigue scores after surgery. Patients with low-grade gliomas more often reported low fatigue before surgery and high fatigue after surgery, while patients with high-grade gliomas more often reported high fatigue before surgery and low fatigue after surgery. Our findings indicate that fatigue is a common symptom in patients with diffuse glioma, both pre- and postoperatively. Perioperative changes were frequently seen. This is important knowledge when informing patients before and after surgery.
Identifiants
pubmed: 31974804
doi: 10.1007/s11060-020-03403-0
pii: 10.1007/s11060-020-03403-0
pmc: PMC7075831
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-107Références
J Neurooncol. 2006 Feb;76(3):283-91
pubmed: 16163448
Lancet Neurol. 2007 May;6(5):421-30
pubmed: 17434097
Nat Rev Clin Oncol. 2014 Oct;11(10):597-609
pubmed: 25113839
Chin J Cancer. 2014 Jan;33(1):40-5
pubmed: 24384239
J Neurooncol. 2015 Dec;125(3):503-30
pubmed: 26530265
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
World Neurosurg. 2018 Sep;117:e465-e474
pubmed: 29920391
Cancer. 2010 Jun 1;116(11):2707-15
pubmed: 20235192
Health Qual Life Outcomes. 2016 Jun 07;14:87
pubmed: 27267486
JAMA. 2012 Nov 14;308(18):1881-8
pubmed: 23099483
Acta Neurol Scand. 2010 Sep;122(3):159-67
pubmed: 20298491
J Health Soc Behav. 1983 Dec;24(4):313-24
pubmed: 6668411
Neuro Oncol. 2015 Oct;17(10):1393-401
pubmed: 25972454
J Clin Oncol. 1998 Mar;16(3):1188-96
pubmed: 9508207
Curr Neurol Neurosci Rep. 2013 Jul;13(7):359
pubmed: 23666388
N Engl J Med. 2016 Apr 7;374(14):1344-55
pubmed: 27050206
Neuro Oncol. 2016 Jun;18(6):849-54
pubmed: 26902850
Support Care Cancer. 2018 Oct;26(10):3353-3364
pubmed: 29961146
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88
pubmed: 29117289
Support Care Cancer. 2012 Oct;20(10):2315-25
pubmed: 22160582
Ann Oncol. 2017 Aug 1;28(8):1942-1948
pubmed: 28475680
Patient Educ Couns. 2010 Apr;79(1):112-9
pubmed: 19762197
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Soc Sci Med. 1997 Jul;45(2):231-46
pubmed: 9225411
Neuro Oncol. 2015 Feb;17(2):274-81
pubmed: 25006033
Support Care Cancer. 2006 Dec;14(12):1205-12
pubmed: 16710652
Neuro Oncol. 2019 Feb 19;21(3):370-379
pubmed: 30312433
J Neurooncol. 2003 Jun;63(2):179-86
pubmed: 12825822
Ann Oncol. 2011 Sep;22(9):2107-12
pubmed: 21324954
J Neurooncol. 2009 Mar;92(1):73-8
pubmed: 19066729
N Engl J Med. 2008 Jul 31;359(5):492-507
pubmed: 18669428
J Neurooncol. 1997 Sep;34(3):263-78
pubmed: 9258818
Support Care Cancer. 1997 Sep;5(5):410-3
pubmed: 9322354
Cancer. 2016 Jul 15;122(14):2206-15
pubmed: 27088883
Palliat Med. 2003 Dec;17(8):664-72
pubmed: 14694917
BMC Cancer. 2010 Jun 18;10:305
pubmed: 20565883
Eur J Oncol Nurs. 2010 Dec;14(5):410-6
pubmed: 20363189
Ann Oncol. 2000 Aug;11(8):971-5
pubmed: 11038033
World Neurosurg. 2011 May-Jun;75(5-6):709-15; discussion 604-11
pubmed: 21704941
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Neurol Sci. 2015 Aug;36(8):1363-9
pubmed: 25698127
JAMA Oncol. 2016 Nov 1;2(11):1460-1469
pubmed: 27310651